BRAF Inhibition Increases Tumor Infiltration by T cells and Enhances the Anti-tumor Activity of Adoptive Immunotherapy in Mice

PURPOSE: Treatment of melanoma patients with selective BRAF inhibitors results in objective clinical responses in the majority of patients with BRAF mutant tumors. However, resistance to these inhibitors develops within a few months. In this study, we test the hypothesis that BRAF inhibition in comb...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Liu, Chengwen, Peng, Weiyi, Xu, Chunyu, Lou, Yanyan, Zhang, Minying, Wargo, Jennifer A., Chen, Jie Qing, Li, Haiyan S., Watowich, Stephanie S., Yang, Yan, Frederick, Dennie Tompers, Cooper, Zachary A., Mbofung, Rina M, Whittington, Mayra, Flaherty, Keith T., Woodman, Scott E., Davies, Michael A., Radvanyi, Laszlo G., Overwijk, Willem W., Lizée, Gregory, Hwu, Patrick
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4120472/
https://ncbi.nlm.nih.gov/pubmed/23204132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-1626
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars